Showing results (271-280 of 609) with videos related to
Sort By:
Pageof 61
International Psychogeriatrics|September 24, 2002
A randomized, placebo-controlled trial of the discontinuation of long-term antipsychotics in dementiaRobert van Reekum, Diana Clarke, David Conn, et al.Canadian Geriatrics Journal : CGJ|July 17, 2015
Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment?Brittany Intzandt, Sandra E Black, Krista L Lanctôt, et al.Journal of the American Heart Association|December 24, 2022
Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class ApproachMyuri Ruthirakuhan, Hugo Cogo-Moreira, Walter Swardfager, et al.Frontiers in Psychiatry|June 12, 2018
Validity of the QUADAS-2 in Assessing Risk of Bias in Alzheimer's Disease Diagnostic Accuracy StudiesAlisson Venazzi, Walter Swardfager, Benjamin Lam, et al.Journal of Geriatric Psychiatry and Neurology|February 23, 2019
Screening for Post-Stroke Depression and Cognitive Impairment at Baseline Predicts Long-Term Patient-Centered Outcomes After StrokeArunima Kapoor, Krista L Lanctot, Mark Bayley, et al.The American Journal of Geriatric Pharmacotherapy|December 11, 2012
Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sexConnie Marras, Nathan Herrmann, Geoffrey M Anderson, et al.Neurodegenerative Disease Management|October 19, 2017
Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer's diseaseCelina S Liu, Allison Rau, Damien Gallagher, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 16, 2002
Central serotonergic activity is related to the aggressive behaviors of Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Goran Eryavec, et al.Journal of Abnormal Psychology|March 26, 2014
Autobiographical episodic memory in major depressive disorderHedvig Söderlund, Morris Moscovitch, Namita Kumar, et al.Journal of the American Medical Directors Association|October 21, 2015
A Randomized Placebo-Controlled Discontinuation Study of Cholinesterase Inhibitors in Institutionalized Patients With Moderate to Severe Alzheimer DiseaseNathan Herrmann, Jordana O'Regan, Myuri Ruthirakuhan, et al.Pageof 61